Effect of numerical representations of risk on perception.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to M D Mehta.
Explore the source record for details and available documents.
This study examined the correlations of ratings of expectation of a future disaster in a nuclear power plant and estimation of its consequences in a random sample of 150 adults who lived within two kilometers of a nuclear power plant. Analysis suggested a significant positive but low relation. This finding indicates that risk perception might be explored using constellations of beliefs and attitudes toward hazards without invoking personality characteristics like trait anxiety or demographic variables such as gender.
This study explored how trait anxiety interacts with various demographic variables in influencing how potential nuclear power disaster is assessed by a random sample of 150 adults (77 women, 73 men) who live near a nuclear power plant. Expectation of a future nuclear power plant disaster was positively related to high trait-anxiety elevations in women who were childless.
Cefditoren (ME 1206) is a new cephalosporin available for oral administration as the pivaloyloxymethyl ester (ME 1207). The effect of medium formulation. pH, cation concentration and inoculum on the in vitro activity of cefditoren was investigated prior to determining its comparative antibacterial potency against a wide range of clinical bacterial isolates, its bactericidal activity against susceptible strains and the duration of its post-antibiotic effect (PAE). Cefditoren was shown to possess a broad-spectrum of cidal antibacterial activity against both Gram-positive and Gram-negative species with stability to many beta-lactamases of clinical importance. Its activity against Gram-positive species was similar to augmentin and cefuroxime, but superior to that of cefaclor and cefixime, while its beta-lactamase stability was similar to that of cefixime and ceftazidine, characterizing it as a third generation cephalosporin. Investigation of the effect of laboratory variables on the in vitro activity of cefditoren indicates that it will present no special problems when tested in the clinical setting against bacterial pathogens. PAE of 0.9 h, or greater, for Staphylococcus spp, Streptococcus pneumoniae and Moraxella catarrhalis may support the use of an extended dose-interval when cefditoren is used for the treatment of respiratory tract infections.
The role of the anaesthetist in the continuing care of patients suffering from chronic pain has been discussed. Many of the techniques, both invasive and non-invasive, which are currently available for the treatment of chronic pain have been reviewed.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.